Entering text into the input field will update the search result below

GW Pharmaceuticals narrows loss in Q4, revenue beats

Feb. 25, 2020 4:35 PM ETGW Pharmaceuticals plc (GWPH) StockGWPHBy: Liz Kiesche, SA News Editor15 Comments
  • GW Pharmaceuticals (NASDAQ:GWPH) Q4 net loss of $24.9M, or 7 cents per share, narrows from net loss of $71.9M, or 20 cents per share, in the year-ago quarter.
  • Per-share loss compares with consensus of 3-cent-per-share loss.
  • Q4 revenue of $109.1M beats the $104.3 consensus and jumped from $6.65M in the year-ago quarter.
  • Q4 Epidiolex net product sales were $104.5M.
  • The company's 2020 focus is on broadening prescriber base, expanding payer coverage, entering long term care segment, and expected launch of TSC indication.
  • At year-end 2019, GWPH had cash and cash equivalents of $536.9M vs. $591.5M at the end of 2018.
  • Previously: GW Pharmaceuticals EPS misses by $0.03, beats on revenue (Feb. 25)

Recommended For You

Related Stocks

SymbolLast Price% Chg
GWPH--
GW Pharmaceuticals plc